7 bibliography - inflibnetshodhganga.inflibnet.ac.in/bitstream/10603/50606/7/18...bibliography 179 7...
Post on 27-Dec-2019
4 Views
Preview:
TRANSCRIPT
BIBLIOGRAPHY
179
7 BIBLIOGRAPHY
A. A. Attama, P. A. Akpa, L. E. Onugwu, G. Igwilo;(2008). Novel buccoadhesive
delivery system of hydrochlorothiazide formulated with ethyl cellulose
-hydroxypropyl methylcellulose interpolymer complex, Scientific Research and
Essay; 3(6):343-347.
A. E. Benson; (2005). Transdermal drug delivery; Penetration enhancement techniques;
Current drug delivery; 2: 23-33.
Aiman A. Obaidat, Rana M. Obaidat;(2011). Development and evaluation of fast-
dissolving tablets of Meloxicam- β-cyclodextrin complex prepared by direct
compression, Acta Pharm; 61(1):83–91.
Alfred Martin, James Swarbrick, Arthur Cammarata;(1991). Polymer Science, In chapter
22 of, Physical Pharmacy: Physical chemical principles in the pharmaceutical
sciences, 3rd Indian ed., K. M. Varghese Company, Bombay; 614-616.
Amit Chaudhary, Upendra Nagaich, Neha Gulati, V. K. Sharma, R. L. Khosa;(2012).
Enhancement of solubilization and bioavailability of poorly soluble drugs by
physical and chemical modifications: A recent review, Journal of Advanced
Pharmacy Education and Research; 2(1):32-67.
Azmail Khan, Syed Sanaullah, Md. Liyakat Ahmed, Aejaz Ahmed;(2010). In -vivo
efficacy study of Aceclofenac solid dispersion incorporated gels for transdermal
delivery on Rats, Asian J. Exp. Biol. Sci.; 1(3):602-5.
BIBLIOGRAPHY
180
B AnilReddy;(2010), In-vitro characterization and evaluation of transdermal drug
delivery system for Metoprolol Tartarate. Journal of Pharmaceutical Research and
Health Care; 2(4):325-329.
B. C. Finnin, T. M. Morgan;(1999). Transdermal penetration enhancers: limitations, and
potential. Journal of Pharmaceutical Sciences; 88:955 – 958.
B. J. Thomas, B. C. Finnin;(2004). The transdermal revolution, Drug Discovery Today;
9, 697 - 703.
Banakar U. V., Swarbrick J.;(1992). Drug and Pharmaceutical Sciences, 49, Marcel
Dekker, New York, 407.
Bellantone N.H., Rim S., Rasadi B.;(1980). Enhanced percutaneous absorption via
Iontophoresis. Evaluation of an in-vitro system and transport of model compound.,
Int. J. Pharm.; 30, 63-72.
Bharadwaj R, Dorr RT, Blanchard J.;(2000). Approaches to reducing toxicity of
parenteral anticancer drug formulations using cyclodextrins. J. Pharm. Sci. Technol;
54:233–9.
Bharkatiya M., Nema R. K.;(2006). Designing and evaluation of patches of Nimesulide,
Asian J. Pharm.; 1(1):46-48.
Bhattacharya A, Ghosal S.K.;(2000). Preparation of matrix type transdermal drug
delivery of Ketotifen Fumarate, Eastern Pharmacist; (3):109-11.
Bodor, N.S.; Huang, M-J.; Watts, J.D; (1995) Theoretical studies on the structures of
natural and alkylated cyclodextrins. J. Pharm. Sci.; 84(3), 330-336.
BIBLIOGRAPHY
181
Botsi, A.; Yannakopoulou, K.; Perly, B.; Hajoudis;(1995), Positive or Adverse Effects of
Methylation on the Inclusion Behaviour of Cyclodextrins. A Comparative NMR
Study Using Pheromone Constituents of the Olive Fruit Fly, E. J. Org. Chem.;
60(13), 4017-4023.
Bouchemal K., Briançon S., Fessi H., Chevalier Y. , Bonnet I., Perrier E.;(2006).
Simultaneous emulsification and interfacial polycondensation for the preparation of
colloidal suspension of nanocapsules, Material Science and Engineering; 26(2-3),
472–480.
Brandner, J.M., Kief, S., Grund, C., Rendl, M., Houdek, P., Kuhn, C., Tschachler, E.,
Franke, W.W., Moll, I.;(2002). Organization and formation of the tight junction
system in human epidermis and cultured keratinocytes. Eur. J. Cell. Biol.; 81:253–
263.
Chakole C M, Shende M A, Khadatkar S N;(2009). Formulation and development of
novel combined Halobetasol propionate and Fusidic acid ointment, Int. J. Chem.
Tech. Res.; 1(1): 103–116.
Charro B.D., Guy R.H.;(2001). Transdermal drug delivery in Drug delivery & targeting,
Hillery A. M., Lloyd A.W., Swarbrik J. edition I., Published by Taylor & Francis.
NY, US, 216-217.
Chen K., Schmidt C F.;(1925). The action of ephedrine, the active principle of Chinese
drug, J. Pharmacology. Exp. Ther.; 24:339-357.
Chien Y W.;(2009). Drugs and the Pharmaceutical Sciences: Novel drug delivery system.
2nd edition. Informa Healthcare; 50:301-375.
BIBLIOGRAPHY
182
Chien Y.W.;(1991). Systemic delivery of pharmacologically active molecules across skin
in Targeted drug delivery, Radolph L., Juliano(Editor) Springer- Verlag, Berlin, 182-
230.
Chien Yie.W.;(1988). Drug delivery polymers used in the development of transdermal
delivery system. Indian Journal of Pharmaceutical Sciences; 3(4):50-63.
Chiou WL;(1977). Pharmaceutical applications of solid dispersion systems: X-ray
diffraction and aqueous solubility studies on Griesofluvin-polyethylene glycol 6000
systems. J Pharm Sci.; 66:989-91.
Couvreur P., Barrat G., Fattal E., Legrand P., Vauthier C.;(2002). Nanocapsule
technology, Critical Reviews in Therapeutic Drug Carrier Systems, 19(2), 99-134.
D. P. Patel; (2011). Formulation and evaluation aspects of transdermal drug delivery
system. International Journal of Pharmaceutical Research and Development.;6 (2) :
83-90.
Danester Quiñones, M S; Evone S. Ghaly;(2008). Formulation and characterization of
Nystatin gel, Puerto Rico Health Sciences Journal; 27(1):61-7.
David C. Bibby, Nigel M. Davies, Ian G. Tucker;(2000). Mechanisms by which
cyclodextrins modify drug release from polymeric drug delivery systems,
International Journal of Pharmaceutics; 197, 1(2):1–11.
Deepthi Mathew;(2009). A study on suitability of Nimesulide-betacyclodextrin complex
in oral and topical dosage forms, International Journal of Pharmacy and
Pharmaceutical Sciences; 1(1):193-198.
BIBLIOGRAPHY
183
Degner, F., Sigmund, R., Zeidler, H.;(2000). Efficacy and tolerability of Meloxicam in an
observational, controlled cohort study in patients with rheumatic disease, Clinical
Therapeutics; 22: 400–410.
Dey S, Malgope A;(2010). Preparation of Carvedilol transdermal patch and the effect of
Propylene Glycol on permeation, International Journal of Pharmacy and
Pharmaceutical Sciences; 2(1):137-143.
Draize J H, Woodard G, Calvery H O;(1944). Methods for the study of irritation and
toxicity of substances applied topically to the skin and mucous membranes, J
Pharmacol Exp Ther; 82:377–390.
Dufosse L, Souchon I, Feron G, Latrasse A, Spinnler H E.;(1999). In situ detoxification
of the fermentation medium during gamma-decalactone production with the yeast
Sporidiobolus salmonicolor. Biotechnol Prog;15:135–9.
E M Martin Del Valle;(2004). Cyclodextrins and their uses: A review. Process
Biochemistry; 39: 1033-1046.
El-Gamal M I, Bayomi S M, El-Ashry S M, Said S A, Abdel-Aziz A A, Abdel-Aziz N I;
(2010). Synthesis and anti-inflammatory activity of novel (substituted) benzylidene
acetone oxime ether derivatives: molecular modeling study. European Journal of
Medicinal Chemistry; 45: 1403-1414.
Elias, P M;(1981), Epidermal lipids, membranes, and keratinization, Int. J. Dermatol.;
20:1-19.
BIBLIOGRAPHY
184
Elias, P.M., Cooper, E.R., Korc, A., Brown, B.E.;(1981). Percutaneous transport in
relation to stratum corneum structure and lipid composition. J. Invest. Dermatol.; 76:
297–301.
Engelhardt G, Bogel R, Schnitzer C, Utzmann R.;(1996). Meloxicam: Influence on
Arachidonic acid metabolism. Biochemical Pharmacology; 51(1), 21-8.
Engelhardt G, Homma D, Schlegal K, Utzmann R, Schinitzler C.;(1995). Anti-
inflammatory, analgesic, antipyretic and related properties of Meloxicam, a new
non-steroidal anti-inflammatory agent with favourable gastro intestinal tolerance.
Inflamm Res.; 44:423-33.
Eseldin K, Rakesh K S, Esmaeil B M, Abd-alkadar Z A.;(2002). Transdermal drug
delivery system – Design and evaluation, International Journal of Advances in
Pharmaceutical Sciences; (1), 201-211.
Eskandar Moghimipour, Mohammad Ali Dabbagh, Anayattollah Salimi, Bahareh Rezaee,
Behzad Ehdaie;(2012). Characterization of Glycolic Acid transdermal gel: The
impact of polymeric base and co-solvent on release pattern, Journal of
Pharmaceutical and Biomedical Sciences; 2(5):53-58.
Fahmy, M.;(2006). Ca-alginate beads loaded with Meloxicam: effect of alginate
chemical composition on the properties of the beads and ulcerogenicity of the drug.
Journal of Drug Delivery Science and Technology; 16, 183–189.
Frank M M, Fries L F;(1991). The role of complement in inflammation and phagocytosis.
Immunology Today; 12: 322-326.
BIBLIOGRAPHY
185
Franklin P X, Pillai A D, Rathod P D, Yerande S, Nivsarkar M, Padh H, Vasu K K,
Sudarsanam V.;(2008). 2-Amino-5-thiazolyl motif: a novel scaffold for designing
anti-inflammatory agents of diverse structures. European Journal of Medicinal
Chemistry; 43: 129-134.
French, D.; Pulley, A. O.; Effenberger, J. A.; Rougvie, M. A.; Abdullah, M. Arch.;
(1965). Studies on the Schardinger dextrins. XII. The molecular size and structure of
the delta-, epsilon-, zeta-, and eta-dextrins. Biochem. Biophys.;111(1):, 153-160.
Fromming, K.H.; Szejtli, J.;(1994). Cyclodextrins in Pharmacy; Kluwer Acad. Publ.:
Dordrecht, 13-15.
Fujishima N, Kusaka K, Umino T, Urushinata T, Terumi K.;(2001). Flour based foods
containing highly branched cyclodextrins. Japanese Patent JP 136,898.
Gambero, A., Becker, T. L., Zago, A. S., De Oliveira, A. F., Pedrazzoli JR., J. ;(2005).
Comparative study of anti-inflammatory and ulcerogenic activities of different
cyclo-oxygenase inhibitors, Inflammopharmacology; 13(5): 441–454.
Gros L., Clark W.E., (1980). The structure of skin in The tissue of the body, Le Gros and
Clark W. E., edition VI, ELBS and Oxford University Press, London, 29-3.
Gupta G.D., Gaud R.S.;(2005) . Release rate of Tenoxicam from acrypol gels, The
Indian Pharmacist; 69-75.
Gupta, S. K., Bansal, P., Bhardwaj, R. K., Jaiswai, J., Velpandian, T;(2002). Comparison
of analgesic and anti-inflammatory activity of Meloxicam gel with Diclofenac and
Piroxicam gel in animal models: Pharmacokinetic parameters after topical
application, Skin Pharmacology and Applied Skin Physiology, 15:105–111.
BIBLIOGRAPHY
186
Hamza Y S, Aburahma M H;(2009). Design in-vitro evaluation of novel sustained release
double layer tablets of Lornoxicam: Utility of cyclodextrin and xanthan gum
combination. AAPS Pharm SciTech. 10(4): 1357-1367.
Hanft, G., Turck, D., Scheuerer, S., Sigmund, R.;(2001). Meloxicam oral suspension: a
treatment alternative to solid Meloxicam formulations, Inflammation Research,
50(13), 35–37.
Hashimoto, H.;(1991). In New trends in cyclodextrins and derivatives; Ducheˆne, D. Ed.;
Edition de Sante´, Paris, 3, 97-156.
Hedges R A.;(1998). Industrial applications of cyclodextrins. Chem Rev; 98:2035–44.
Higuchi T., (1963). Theoretical Analysis of rate of release of medicaments from ointment
bases containing in Solid Matrices, J. Pharm. Sci., 52, 1145- 1149.
Higuchi T., Connors K. A.;(1965). Phase solubility techniques, Adv. Anal. Chem.
Inatrum. 4:170-210.
Higuchi, T.; Connors, K. A.;(1965). In Advances in Analytical Chemistry and
Instrumentation; Reilly, C. N., Ed.; Wiley-Interscience: New York, 4:117-212.
Holland L, Rizzi G, Malton P;(1999). Cosmetic compositions comprising cyclic
oligosaccharides and fragrance. PCT Int Appl WO 67,716.
Howard C. Ansel, Loyd V. Allen, Jr., Nicholas G., Popovich;(2000). Disperse systems,
Ch. 13., in Pharmaceutical dosage forms and Drug delivery systems, 7th ed.,
Lippincott Williams and Wilkins, Philadelphia, 375.
Howard C. Ansel, N.G. Popovich, Allen, V. Loyd; (2005). Pharmaceutical Dosage Forms
and Drug Delivery Systems, 8th Edn., B. I. Publications Pvt. Ltd., 2005, 418.
BIBLIOGRAPHY
187
ICH Guidelines, Stability testing of new drug substances and products, 27th October
(1993).
Jain N K, Jain S, Bhadra D;(2010). Transfersomes – A novel carrier for effective
transdermal drug delivery. In: Jain N K. Controlled and novel drug delivery. 1st
edition, CBS publisher and Distributors Pvt. Ltd. 426-448.
Jantharaprapap, R., Stagni, G. ; (2007). Effects of penetration enhancers on in-vitro
permeability of Meloxicam gels, International Journal of Pharmaceutics,
343(1):26–33.
Jung S.;(2003). Novel compounds for skin penetration enhancement, The UCI
Undergraduate Research Journal,5(1):25-29.
K V. Vilegave, S P. Hiremath, P M. Chandankar, M S. Sanap, V T. Sathe, A V. Patil, M.
Kharjul;(2012). Formulation, characterization and evaluation (in-vivo-in-vitro study)
of matrix type Transdermal patches of Carvedilol; International Journal of Research
in Pharmacy and Chemistry, 2(3): 828-852.
Kadam S S, Mahadik K R, Bothara K G.;(2008). Principles of Medicinal Chemistry. 18th
edition. Nirali Prakashan.; 2: 255-273.
Kandavilli S, Nair V, Panchagnula R, (2002). Polymers in transdermal drug delivery
systems. Pharmaceutical Technology; May: 62-80.
Kanikannan N, Kandimalla K, Lamba S S, Sing M; (1999). Structure activity relationship
of chemical permeation enhancers in transdermal drug delivery; Current Med. Chem.
6(7): 593-608.
BIBLIOGRAPHY
188
Kassuya C A, Cremoneze A, Barros L F L, Simas A S, Lapa F R, Mello-Silva R,
Stefanello M E, Zampronio A R;(2009). Antipyretic and anti-inflammatory
properties of the ethanolic extract, dichloromethane fraction and costunolide from
Magnolia ovate (Magnoliaceae). Journal of Ethnopharmacology; 124:369-376.
Kim H., Lee I.;(2007). A novel drug delivery system design for Meloxicam, J. Pharm
Pharmaceut Sci, 10 (3), 288-298.
Kinne R W, Brauer R, Stuhlmuller B, Palombo-Kinne E, Burmester G R;(2000).
Macrophages in rheumatoid arthritis. Arthritis Research, 2: 189-202.
Kooriyattil Naseera, C I Sajeeth, K Santhi;(2012). Formulation, optimization and
evaluation of matrix type of transdermal system of Simvastatin using permeation
enhancers; International Journal of Current Pharmaceutical Research, 4(2):79-87.
Korsmeyer R W, Gurny R, Doelker E, Buri P., Peppas N A;(1983). Mechanisms of solute
release from porous hydrophilic polymers, International Journal of Pharmaceutics,
15(1), 25-35.
Lambert G., Fattal E., Pinto-Alphandary H., Gulik A., Couvreur P.;(2000).
Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel
colloidal carrier for the delivery of oligonucleotides, Pharmaceutical Research,
17(6), 707-714.
Lampe, M.A., Burlingame, A.L., Whitney, J., Williams, M.L., Brown, B.E., Roitman, E.,
Elias, P.M.;(1983). Human stratum corneum lipids: characterization and regional
variations. J. Lipid Res., 24:120–130.
BIBLIOGRAPHY
189
Langbein, L., Grund, C., Kuhn, C., Praetzel, S., Kartenbeck, J., Brandner, J.M., Moll, I.
Franke,W.W.;(2002).Tight junctions and compositionally related junctional
structures in mammalian stratified epithelia and cell cultures derived there from.
Eur. J. Cell Biol., 81:419-35.
Lenuţa-Maria Miclea, Lavinia Vlaia, V. Vlaia, Daniel L. Hădărugă, Constantin Mircioiu;
(2010). Preparation and characterization of Inclusion complexes of Meloxicam and
α-cyclodextrin and β-cyclodextrin, Farmacia, 58(5):583-93.
Lipscomb, G. R., Wallis, N., Armstrong, G., Rees, W. D. W.;(1998). Gastrointestinal
tolerability of Meloxicam and Piroxicam: A double-blind placebo controlled study,
Brazilian Journal of Clinical Pharmacology, 46:133–137.
Loftsson T, Brewster M E.;(1996). Pharmaceutical applications of cyclodextrins: Drug
solubilisation and stabilization. J Pharm Sci,85:1017–25.
Loftsson T, Duchene D.;(2007). Cyclodextrins and their pharmaceutical applications. Int
J of Pharm.; 329: 1–11.
Loftsson T, Ólafsdóttir B J, Fridriksdóttir H, Jónsdóttir S.;(1993). Cyclodextrin
complexation of NSAIDs: Physicochemical characteristics. Eur J Pharm Sci;1:95–
101.
Loftsson T, Stefansdottir Ó, Fridriksdottir H, Gudmundsson Ö.;(1992). Interaction
between preservatives and 2-hydroxypropyl-β-cyclodextrin, Drug Dev. Ind.
Pharm;18(13):1477–84.
Loftsson, T., Masson, M.; (2001). Cyclodextrins in topical drug formulations: Theory and
Practice. Int J Pharm.; 225:15-30.
BIBLIOGRAPHY
190
Lucas S M, Rothwell N J, Gibson R M;(2006). The role of inflammation in CNS injury
and disease. British Journal of Pharmacology; 147: 232-240.
M Najmuddin, A A Mohsin, Tousif Khan, V Patel, S Shelar;(2010). Formulation and
evaluation of solid dispersion incorporated gel of Ketoconazole, Research Journal of
Pharmaceutical, Biological and Chemical Sciences, 1(2):406-12.
M. Aqil, Y. Sultana, A. Ali.;(2006). Transdermal delivery of β-blockers. Expert opinion,
3: 405-418.
Malay K. Das, A. Bhattacharya., S. K. Ghosal.;( 2006). Transdermal delivery of
Trazodone hydrochloride from acrylic films prepared from aqueous extract, Ind. J.
Pharm Sci., 68(1):41-46.
M. R. Prausnitz, S. Mitragotri, R. Langer;(2004). Current status and future potential of
transdermal drug delivery. Nat. Rev. Drug Discov., 3: 115-124.
M. V. Nagabhushanam;(2010). Formulation studies on cyclodextrin complexes of
Meloxicam. International Journal of Pharmacy and Technology; 2(1), 89-102.
Maincent P., Le Verge R, Sado P., Couvreur P., Devissaguet J.P.;(1986). Disposition
kinetics and oral bioavailability of vincamine-loaded polyalkyl cyanoacrylate
nanoparticles, Journal of Pharmaceutical Science; 75(10),955 - 958.
Manivannan Rangasamy, Ayyasamy Balasubramaniam, Sandeep Gummadevelly;(2008).
Design and Evaluation of β-cyclodextrin Complexes of Meloxicam Tablet, Research
J. Pharm. and Tech.; 1(4):484-6.
BIBLIOGRAPHY
191
Manvi F V, Dandagi P M, Gadad A P, Mastiholimath V S, Jagadeesh T;(2003).
Formulation of a transdermal drug delivery system of Ketotifen fumarate, Indian J
Pharm Sci; 65(3):239-43.
Mario G., Gabriele G.;(2005). Mathematical Modelling and Controlled Drug Delivery:
Matrix Systems, Current Drug Delivery, 2, 97-116.
Masson, Thorstein, Loftsoon, Gisli Masson, Einar Stefansson;(1999). Cyclodextrins as
permeation enhancers; Some theoretical evaluations and in-vitro testing, Journal of
Control Release; 59(1),107-18.
Mbela T.K.M., Poupaert J.H., Dumont P.;(1992). Poly (diethylmethyldene malonate)
nanoparticles as primaquine delivery system to liver, International Journal of
Pharmacy; 79(1), 29-38.
Misra A N., (2004). Transdermal drug delivery. In: Jain N K. Controlled and novel drug
delivery. 1st edition. CBS publisher and Distributors Pvt. Ltd. 100-130.
Miyazawa H, Ueda H, Nagase T, Endo T, Kobayashi S, Nagai T.;(1995).
Physicochemical properties and inclusion complex formation of δ-cyclodextrin. Eur
J Pharm Sci.;3:153-162.
Mohd. Amjad, Mohd. Ehtheshamuddin, S. Chand, Hanifa, M. Sabreesh1, R. Asia, G. S
Kumar;(2011). Formulation and evaluation of transdermal patches of Atenolol,
Advance research in Pharmaceuticals and Biologicals; 1(2):109-19.
Montasser I., Fessi H., Coleman A.W.;(2002). Atomic force microscopy imaging of
novel type of polymeric colloidal nanostructures, European Journal of
Pharmaceutics and Biopharmaceutics; 54(3), 281-284.
BIBLIOGRAPHY
192
Morita, K., Itoh, M., Saitou, M., Ando-Akatsuka, Y., Furuse, M., Yoneda, K., Imamura,
S., Fujimoto, K., Tsukita, S.;(1998). Subcellular distribution of tight junction
associated proteins (occludin, ZO-1, ZO-2) in rodent skin. J. Invest. Dermatol.; 110:
862–866.
Muñoz-Botella S, Del Castillo B, Mart˝yn M A.;(1995). Cyclodetrin properties and
applications of inclusion complex formation. Ars Pharm; 36:187–98.
Murthy S N; Hamsa V, Bhaskaran;(1995). Comparative release studies of transdermal
films of Terbutaline sulphate across various diffusion barriers. Ind J Pharm Sci.;
57(5); 207-9.
Mutimer M N, Reffkin C, Hill J A, Marry E, Glickman M., Cry G N;(1956). Modern
ointment base technology II. J. Am. Pharm. Assoc. Sci;, 45:212-20.
N. K. Jain, A. N. Misra;(2005).Controlled and Novel Drug Delivery, CBS Publishers and
Distributors, New Delhi,
Nash, R. A; (1994). In Handbook of Pharmaceutical Excipients; Wade, A., Weller, P. J.,
Eds.; Am. Pharm. Assoc. & Phar. Press: London, 145-148.
Nathan C;(2002). Points of control in inflammation. Nature; 420: 846-852.
Nayak S H, Nakhat P D, Yeole P G;(2004). Transdermal drug delivery system. Indian
Pharmacist; 3(27):7-14.
Nelson H.S;(1995). Beta adrenergic bronchodilator, N. Eng. J. Med.; 333(8): 499-506.
BIBLIOGRAPHY
193
Nikhil Kasliwal, Dilip Derle, Jeetendra Negi, Kushal Gohil;(2010). Effect of permeation
enhancers on the release and permeation kinetics of Meloxicam gel formulations
through rat skin. Asian Journal of Pharmaceutical Sciences; 3(5):193-199.
Nirav S Sheth, Rajan B Mistry;(2011). Formulation and evaluation of transdermal
patches and to study permeation enhancement effect of Eugenol; Journal of Applied
Pharmaceutical Science; 1(3):96-101.
Obaidat A. A., Khanfar R. A., Khawam M. N.;(2011). The effect of β-cyclodextrin on the
solubility and dissolution rate of Meloxicam and investigation of the driving force
for complexation using molecular modeling, J. Incl. Phenom. Macrocycl. Chem.;
63(3):273-279.
Parthasarathy G, Bhaskar Reddy K, Prasanth V V;(2011). Formulation and
characterization of transdermal patches of Naproxen with various polymers,
Pharmacie Globale International Journal of Comprehensive Pharmacy; 2(6):1-3.
Patel D, Patel N, Parmar M, Kaur N(2011), Transdermal drug delivery system: Review.
International Journal of Biopharm and Toxicological Research; 1(1): 61-80.
Patel N B, Sonpal R N, Mohan S, Selvaraj S;(2010). Formulation and evaluation of
iontophoretic transdermal delivery of Diltiazem Hydrochloride, Int. J. Res. Pharm.
Sci.; 1(3):338-344.
Pavia D L, Lampman G M, Kriz G S;(2001). Introduction to Spectroscopy. 3rd edition.
Thomson Learning; 14-82.
BIBLIOGRAPHY
194
Pitha J, Hoshino T;(1992). Effects of ethanol on formation of inclusion complexes of
hydroxypropylcyclodextrins with testosterone or with methyl orange, Int J Pharm;
80(2):243–51.
Pitha J, Milecki J, Fales H, Pannell L, Uekama K;(1986). Hydroxypropyl-β-cyclodextrin:
preparation and characterization; effects on solubility of drugs. Int J Pharm.; 29:73–
82.
Pitha, J., Rao, C. T.,Lindberg, B., Seffers, P. ;(1990). Distribution of substituents in 2-
hydroxy propyl ethers of cyclomaltoheptaose, Carbohydr. Res.; 200, 429-435.
Pummi, K. Malminen, M.H., Aho, S.L., Karvonen, J., Peltonen, S,(2001). Epidermal
tight junctions: ZO-1 and occludin are expressed in mature, developing, and affected
skin and in-vitro differentiating keratinocytes. J. Invest. Dermatol.; 117: 1050–1058.
R. H. Guy;(1996). Current status and future prospects of transdermal drug delivery.
Pharmaceutical Research; 13:1765-69.
Rajan Rajabalaya, Choo Hwai Qin, Sheba Rani Nakka David;(2012). Development and
in-vitro evaluation of matrix type transdermal delivery of Ondansetron
Hydrochloride; International Journal of Drug Delivery; 4(1):125-133.
Rajendrakumar K, Pralhad T, Madhusudan S;(2004). Comparative study on co-ground
products of Rofecoxib with β-cyclodextrin and its Sulfobutyl Ether-7 derivative in
solution and in the solid state. J Incl Phenom.; 49(3-4):259-266.
Rathbone M J, Hadgraft J, Roberts M S (eds.);(2004). Modified release drug delivery
technology. New York, Marcel Dekker, Inc., 126: 471-619.
BIBLIOGRAPHY
195
Reddy M N, Rehana T, Ramakrishna S, Chowdary K P R, Diwan P V;(2004).
β-cyclodextrin complexes of Celecoxib: molecular-modeling, characterization, and
dissolution studies. AAPS PharmSci.; 6(1):1-9.
Redenti, E.; Szente, L.; Szejtli, J;(2001). Cyclodextrin complexes of salts of acidic drugs
thermodynamic properties, structural features, and pharmaceutical applications, J.
Pharm. Sci.; 90(8), 979–986.
Ritschel W A, Hussain A S;(1998). The principles of permeation of substances across the
skin. Methods Find Exp Clin Pharmacol; 10(1):39-56.
Robbins, Cotran;(2005). Pathologic Basis of Disease, 7th Edition, Elsevier, 47-86.
Roux M, Perly B, Djedaini Pilard F.;(2007). Self-assemblies of amphiphilic
cyclodextrins. Eur Biophys J.; 36(8): 861–867.
Rowe R C, Sheskey P J, Quinn M E;(2009). Handbook of Pharmaceutical Excipients. 6th
edition. Pharmaceutical Press and American pharmaceutical Association; 326-329.
S. Amin, S. R. Mir, K. Kohli, A. Ali;(2012). Novel polymeric matrix films for
transdermal delivery of Metoclopramide, International Journal of Pharmaceutical
Frontier Research; 2(1):48-60.
S. Rawat;(2011). Release enhancement of Meloxicam from transdermal gel through
cyclodextrin complexation, International Journal of Pharmaceutical Sciences and
Research; 2(2):357-365.
BIBLIOGRAPHY
196
Sadhana P. Gupta, S.K. Jain;(2005). Development of transdermal delivery of Metoprolol
Tartarate, Indian Journal of Pharmaceutical Sciences; 67(3):346-50.
Sanghavi N.M., Puri R.D.;(1990). Effect of sorption promoters on the transdermal
delivery of Ibuprofen from topical bases, Indian Drugs; 28(10):1-7.
Sanjala Baboota, S P Agarwal; (2002). Inclusion complexes of Meloxicam with β-
cyclodextrin, Indian Journal of Pharmaceutical Sciences; 64(4):408-411.
Sapkal N P, Kilor V A, Bhusari K P, Daud A S.;(2007). Evaluation of some methods for
preparing Gliclazide-β-cyclodextrin inclusion complexes, Tropical Journal of
Pharmaceutical Research; 6(4):833-840.
Sathesh Babu P. R., Subrahmanyam C.V. S.; (2007). Solubility of Meloxicam in Mixed
Solvent Systems; The Ethiopian Pharmaceutical Journal; 25, 23-28
Scheindlin, Stanley;(2004). Transdermal Drug Delivery: Past, Present, Future. Molecular
Interventions. 4(6):308-312.
Schmid G.;(1989). Cyclodextrin glucanotransferse production: yield enhancement by
overexpression of cloned genes. Trends Biotechnol; 7:244–8.
Schneiderman E, Stalcup A M.;(2000). Cyclodextrins: a versatile tool in separation
science. J Chromatogr B; 745:83–102.
BIBLIOGRAPHY
197
Sharma N, Agarwal G, Rana AC, Bhat Z, Kumar D, (2011). A Review: Transdermal drug
delivery system: A tool for novel drug delivery system. International Journal of
Drug Development and Research,3(3), 70-84.
Sheth S K, Patel S J, Shukla J B;(2010). Formulation and evaluation of taste masked oral
disintegrating tablet of Lornoxicam. International Journal of Pharma and Bio
Sciences. 1(2):1-9.
Shivakumar H N, Jamakandi V G, Mulla J S, Vinay B L.;(2009). Formulation,
characterization and evaluation of matrix type transdermal patches of a model
antihypertensive drug, Asian J Pharm.; 3(1): 59-64.
Shukla Vikesh, Masareddy Rajashree, Anghore Ashok, Manvi Fakkirappa.V;(2009).
Influence of β-cyclodextrin complexation on Ketoprofen Release from Matrix
formulation, International Journal of Pharmaceutical Sciences and Drug Research;
1(3): 195-202.
Singh S, Singh J.;(1993). Transdermal drug delivery by passive diffusion and
iontophoresis: a review. Med Res Rev;13:569-621.
Somasundaram Jayaprakash, Sundarapandian Ramkanth, Posina Anitha,
Muthumanickam Alagusundaram, Mohamed T S Saleem, Madhusudhana C Chetty;
(2010). Design and evaluation of monolithic drug-in-adhesive transdermal patches
of Meloxicam, Malaysian Journal of Pharmaceutical Sciences; 8(2):25–43.
Sternon J, Appelboom; (1998). Meloxicam, Revue medicale de Bruxelles. 19(1):29-32.
BIBLIOGRAPHY
198
Subhash P. G., Dinesh B. M., Ravikumar M; (2011). Feasibility of Lercanidipine HCl For
TDDS: Permeation kinetic study in presence of various penetration enhancers,
International Journal of Pharmacy And Pharmaceutical Sciences;3(4):103-7.
Suchika Sharma, Geeta Agarwal, Sanju Dhawan;(2010). Design and evaluation of
Olanzapine transdermal patches containing vegetable oils as permeation enhancers,
Der Pharmacia Lettre, 2(6):84-98.
Swamy N. G. N., Mazhar Pasha, Zaheer Abbas;(2010). Formulation and evaluation of
Diclofenac sodium gels using Sodium Carboxymethyl Hydroxypropyl Guar and
Hydroxypropyl Methylcellulose, Indian Journal of Pharmaceutical Education and
Research; 44(4),310-14.
Szejtli J.;(1998). Introduction and general overview of cyclodextrin chemistry, Chem.
Rev.; 98(5):1743–1753.
Tanwar Y.S, Chauhan C.S, Sharma A.;(2007). Development and evaluation of Carvedilol
transdermal patches. Acta Pharm.; 57:151-159.
Tiwary A K, Sapra B, Jain S,;(2007). Innovations in Transdermal drug delivery:
Formulations and techniques. Recent Patents on Drug Delivery and Formulation; 1:
23-36.
Torres-Labandeira J J, Davignon P, Pitha J.; (1990). Oversaturated solutions of drug in
hydroxypropylcyclodextrins: parenteral preparation of pancratistatin. J Pharm Sci.;
80:384–6.
BIBLIOGRAPHY
199
Tortora G J, Derrickson B.; (2006). Principles of Anatomy and Physiology. 11th edition.
Wiley; 144-170.
Tripathi K D.; (2008). Non-steroidal anti-inflammatory drugs and antipyretic-analgesic.
In: Essentials of Medical Pharmacology. 6th edition. Jaypee Brothers Medical
Publishers (P) Ltd.; 184-210.
Udupa N.; (1992). Iontophoretic drug delivery system, Pharma Times; 24, 9-15.
V. R. Sinha, Maninder Pal Kaur,;(2000). Permeation Enhancers for Transdermal Drug
Delivery, Drug Development and Industrial Pharmacy; 26(11):1131–40.
V.N.L. Sirisha, P. Kirankumar, M. ChinnaEswaraiah; (2012). Formulation and evaluation
of transdermal patches of Propranolol Hydrochloride, IOSR Journal of Pharmacy,
2 (5): 31-37.
Villiers, M.A. ; (1891). Sur la fermentation de la fecule par l'action du ferment butyrique.
Comptes Rendus Acad. Sci. 112, 536-538.
Vinod KR, Sarvani P, Banji D, Teja BB, (2010). Transdermal drug delivery system over
coming challenges of popular drug delivery system. International Journal of
Pharma World Research, 1(3), 1-14.
Vinod L. Gaikwad, Vishal D.Yadav, Rakesh P. Dhavale, Prafulla B. Choudhari, Swapnil
D Jadhav; (2012). Effect of carbopol 934 and 940 on Fluconazole release from
topical gel formulation: A Factorial Approach, Current Pharma Research; 2(2):487-
493.
BIBLIOGRAPHY
200
Vivek Kumar R, Satish Kumar; (2011). Formulation and evaluation Of Mimosa Pudica
Gel, International Journal of Pharmacy and Pharmaceutical Sciences; 3(1):55-57.
Vodovotz Y, Csete M, Bartels J, Chang S, An G ;(2008). Translational systems biology
of inflammation. PLoS Computational Biology; 4: 1-6.
Vogel H G.; (2002). Drug Discovery and Evaluation Pharmacological assays. In chapter
H: analgesic, anti-inflammatory and anti-pyretic activity. 2nd Edition. Springer-
Verlag Heidelberg, New York; 759-61.
Vyas S.P., Khar Roop K.;(2002). Controlled Drug Delivery, 1st Edn., Vallabh Prakashan,
New Delhi.
Watnasirichaikul S., Davies N.M., Rades T., Tucker I.G.;(2002). Preparation of
biodegradable insulin nanocapsules from biocompatible microemulsions,
Pharmaceutical Research; 17(6), 684-9.
Wertz P.W., Medison K.C., Downing D.T. ; (1987). The composition & morphology of
Epidermal cyst lipids., J. Invest. Dermatol.; 89:417-425.
White M; (1999). Mediators of inflammation and inflammatory process. The Journal of
Allergy and Clinical Immunology; 103:378-381.
Williams, M L, Elias, P M; (1987). The extracellular matrix of stratum corneum: role of
lipids in normal and pathological function: Crit Rev. Ther. Drug Carrier Syst.; 3:95-
122.
BIBLIOGRAPHY
201
Xiaoping Z, Sijing C, Guochun T, Zhenmin M. ; (2007). Poly (2-hydroxy-3- phenoxy-
-propylacrylate, 4-hydroxybutyl acrylate, dibutyl maleate) membrane controlled
Clonidine zero-order release, The European Journal of Pharmaceutics and
Biopharmaceutics; 66:429-34.
Y. W. Chien.; (1992). Transdermal drug delivery and delivery systems, in: Y.W. Chien
(Ed), Novel Drug Delivery Systems, 2nd ed., Chapter 7, Marcel Dekker, New York,
301-380.
Yiew W. Chien; (1982). Transdermal controlled release drug administration in Novel
drug delivery system. Edition I, Marcel Dekker, NYUSA, 149-213.
Yogesh M. Amgaokar, Rupesh V. Chikhale, Updesh B. Lade, Dinesh M. Biyani, Milind
J. Umekar; (2011). Design, Formulation and evaluation of transdermal drug delivery
system of Budesonide, Digest Journal of Nanomaterials and Biostructures;
6(2):475-497.
Yu T, Lee J, Lee Y G, Byeon S E, Kim M H, Sohn E H, Lee Y J, Lee S G, Cho J Y;
(2010). In-vitro and in-vivo anti-inflammatory effects of ethanol extract from Acer
tegmentosum. Journal of Ethnopharmacology; 128:139-147.
Yuan, Y., Li, S. M., Mo, F. K., Zhong, D. F.; (2006). Investigation of microemulsion
system for transdermal delivery of Meloxicam, International Journal of
Pharmaceutics; 321(1):117–123.
top related